日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b study

QL1706(一种双功能PD-1/CTLA-4双重阻断剂)在晚期实体瘤中的疗效和预测性生物标志物更新——一项1/1b期研究

Yuxiang Ma ,Shaoyan Lin ,Qun Chen ,Jinhui Xue ,Yunpeng Yang ,Aimin Zang ,Ying Cheng ,Yiping Zhang ,Xiangcai Wang ,Zhendong Chen ,Song Qu ,Jianbo He ,Chuanben Chen ,Chuan Jin ,Dongyuan Zhu ,Qingshan Li ,Xianling Liu ,Wuyun Su ,Yi Ba ,Weiwei Li ,Qian Li ,Changbin Zhu ,Zhan Huang ,Xiaoyan Kang ,Shilin Xue ,Hui Li ,Chao Wang ,Fan Luo ,Yan Huang ,Li Zhang ,Hongyun Zhao

Phase 1b/2 study of ADG106, a 4-1BB/CD137 agonist, in combination with toripalimab in patients with advanced solid tumors

ADG106(一种 4-1BB/CD137 激动剂)联合 toripalimab 治疗晚期实体瘤患者的 1b/2 期研究

Shaoyan Lin ,Yuxiang Ma ,Yongsheng Wang ,Yunpeng Yang ,Jinhui Xue ,Yan Huang ,Yuanyuan Zhao ,Wenfeng Fang ,Shaodong Hong ,Yang Zhang ,Qianwen Liu ,Guizhong Liu ,Xiaohong She ,Jiping Zha ,Songmao Zheng ,Yan Li ,Peter Luo ,Li Zhang ,Hongyun Zhao

Normothermic ex vivo heart perfusion with NLRP3 inflammasome inhibitor Mcc950 treatment improves cardiac function of circulatory death hearts after transplantation

NLRP3 炎症小体抑制剂 Mcc950 进行常温离体心脏灌注治疗可改善移植后循环死亡心脏的心脏功能

Liwei Xu, Zifeng Zeng, Chuanjie Niu, Deshen Liu, Shaoyan Lin, Xiu Liu, Gábor Szabó, Jun Lu, Shaoyi Zheng, Pengyu Zhou

Comments on National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)

关于2022年中国甲状腺癌诊疗指南(英文版)的评论

Wang, Hao; Wang, Jian; Wang, Xiang; Zhu, Yiming; Sun, Yuqing; Zhang, Xin; Hou, Xiaorong; Zheng, Kun; Liu, Shaoyan; Lin, Yansong

Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis

常温离体心脏灌注联合褪黑激素通过抑制 NLRP3 炎症小体介导的细胞焦亡增强大鼠循环死亡后捐献心脏的心肌保护

Jun Lu, Liwei Xu, Zifeng Zeng, Chuqing Xue, Jiale Li, Xiong Chen, Pengyu Zhou, Shaoyan Lin, Yuhui Liao, Xianjin Du, Ronghua Yang, Shaoyi Zheng

A Novel Rat Model of Cardiac Donation After Circulatory Death Combined With Normothermic ex situ Heart Perfusion

一种新型循环死亡后心脏捐献大鼠模型与常温离体心脏灌注相结合

Jiale Li, Chuqing Xue, Xiao Ling, Yu Xie, Desai Pavan, Huimin Chen, Qinbao Peng, Shaoyan Lin, Kunsheng Li, Shaoyi Zheng, Pengyu Zhou

ZJ01, a Small Molecule Inhibitor of the Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction, Reduces Hyperoxic Acute Lung Injury in a Mouse Model

ZJ01 是一种 Kelch 样 ECH 相关蛋白 1-核因子红细胞 2 相关因子 2 (Keap1-Nrf2) 蛋白质-蛋白质相互作用的小分子抑制剂,可减轻小鼠模型中的高氧急性肺损伤

Jun Wan, Shaoyan Lin, Xiuling Huang, Qianqin Li, Lingjun Zeng, Song Du